All Stories

  1. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study

    Article • PLoS ONE, November 2021, PLOS

    Dr Emmanuel A Tsochatzis

  2. Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites

    Article • Liver International, March 2017, Wiley

    Dr Emmanuel A Tsochatzis, Maria Kalafateli, Prof james O'Beirne

  3. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C

    Article • Hepatology, July 2014, Wolters Kluwer Health

    Dr Emmanuel A Tsochatzis